Menu
Recruiting NCT07364708

AC Deflation in Descemet's Membrane Detachment

No phase Interventional Descemet's Membrane Disorder

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: group A will undergo direct intracameral air injection and group B will undergo anterior chamber deflation then intracameral air injection.
Who it may be relevant to
Registry conditions: Descemet's Membrane Disorder. Basic parameters: from 50 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Effect of Anterior Chamber Deflation Before Reduction of a Detached Descemet's Membrane

Overview

using a relatively new technique to manage post-cataract surgery complication and measuring its efficacy

Interventions

  • Procedure group A will undergo direct intracameral air injection and group B will undergo anterior chamber deflation then intracameral air injection
    a group will undergo direct intracameral air injection and another group will undergo anterior chamber deflation then intracameral air injection

Primary outcome measures

  • Rate of complete anatomical reduction of DMD on ASOCT at the 1-week visit. [Time frame: 1 week]
Secondary outcome measures (1)
  • . Time to complete anatomical reduction (days) [Time frame: 1 month]

Eligibility criteria

Inclusion criteria

  • Patients with post cataract surgery DM detachment diagnosed within 1st week postoperatively.
  • Patient age ranges from 50 to 70 years old.

Exclusion criteria

  • Less than one third of Descemet's Membrane is included.
  • Post-operative infection or severe inflammation.
  • Patient with pre-existing glaucoma.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Egypt · 1 center
  • Khalafallah — Minya

Identifiers

NCT: NCT07364708 · 592\7\2025

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗